Axsome Therapeutics Inc (AXSM) returns
Axsome Therapeutics returns over 10 years
$1,000 invested in Axsome Therapeutics ten years ago was worth $21,023 at the close on October 30, 2026, with dividends reinvested: an average return of 35.6% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -21.7% | — | $783.29 | -0.9% |
| 3 months | -38.4% | — | $615.54 | +2.1% |
| Year to date | -20.9% | — | $790.79 | +11.7% |
| 1 year | +8.5% | — | $1,085 | +12.4% |
| 3 years | +140.6% | +34.0% | $2,406 | +88.5% |
| 5 years | +275.1% | +30.3% | $3,751 | +76.0% |
| 10 years | +2,002% | +35.6% | $21,023 | +316.6% |
Axsome Therapeutics return by calendar year
| Year | AXSM | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -20.9% | +11.7% | -32.6% |
| 2025 | +115.9% | +17.7% | +98.1% |
| 2024 | +6.3% | +24.9% | -18.6% |
| 2023 | +3.2% | +26.2% | -23.0% |
| 2022 | +104.2% | -18.2% | +122.3% |
| 2021 | -53.6% | +28.7% | -82.4% |
| 2020 | -21.2% | +18.4% | -39.6% |
| 2019 | +3,565% | +31.2% | +3,534% |
| 2018 | -49.6% | -4.6% | -45.1% |
| 2017 | -17.0% | +21.7% | -38.7% |
| 2016 | -27.2% | +12.0% | -39.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: AXSM financials
No forecast, no recommendation. This page describes Axsome Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.